Aduro BioTech Inc Banner Image

Aduro BioTech Inc

  • Ticker ADRO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Aduro BioTech Inc Logo Image
  • 51-200 Employees
  • Based in Berkeley, California
Aduro BioTech, Inc., a clinical-stage immuno-oncology company, focuses on the development of technology platforms designed to stimulate robust and durable immune responses against cancer. Its lead product candidate is CRS-207, which is in a Phase IIb clinical trial for the treatment of metastatic pancreatic cancer and unresectable malignant pleural mesothelioma.
4.8 / 5.0 (124)

Aduro BioTech Inc reports have an aggregate usefulness score of 4.8 based on 124 reviews.

Aduro BioTech Inc

Most Recent Annual Report

Aduro BioTech Inc
MOST RECENT 2019 Annual Report and Form 10K

Aduro BioTech Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Aduro BioTech Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!